Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Jun. 9, 6:54 AM
Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.
| This Slide: #12 of 100 |
Slide #12. OPKO Health, Inc. — Inspiro Medical Ltd.
Acquirer:
OPKO Health, Inc. (NASDAQ:OPK)
Acquiree:
Inspiro Medical Ltd.
Details:
OPKO Health, Inc. (NYSE:OPK) has entered into a definitive agreement to acquire Inspiro Medical Ltd. ("Inspiro"), an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. Inspiro's Inspiromatic is a "smart" easy-to-use dry powder inhaler with several advantages over existing devices.
Opko Health is a healthcare company. Co.'s reportable segments are: diagnostics, which consists of the clinical laboratory operations of its subsidiary, BioReference Laboratories, Inc. (BioReference), as well as its point-of-care operations; and pharmaceutical, which consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Through BioReference, Co. provides laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare.
OPK SEC Filing Email Alerts Service
Open the OPK Page at The Online Investor »
|
|||||||||||||||||||||
Open the OPK Page at The Online Investor (in a new window) »
 Free OPK Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
 
|
Strong Buy (3.60 out of 4) 61st percentile
(ranked higher than approx. 61% of all stocks covered)
Analysts' Target Price: OPK Stock Forecast Based on Zacks ABR data; powered by Xignite |
